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Rozpowszechnienie palenia tytoniu w populacji miasta Mashhad
(północno-wschodni Iran) i badania czynnościowe płuc u osób palących
Abstract
Introduction: Smoking is known as a major cause of chronic obstructive pulmonary disease (COPD). In this study the
prevalence of smoking in the population of Mashhad city was evaluated as well as pulmonary function tests (PFTs) of
smokers.
Material and methods: The prevalence of smoking was studied using a standard questionnaire. Pulmonary function tests, including
forced vital capacity (FVC), forced expiratory volume in one second (FEV1), maximal mid-expiratory flow (MMEF), peak expiratory flow
(PEF), and maximal expiratory flow at 75%, 50%, and 25% of the FVC (MEF75,50,25), were measured in all smokers.
Results: In total, 1435 individuals were interviewed including 999 males and 436 females. The number of smokers among
the interviewed individuals was 183 (12.7%) including 172 male (17.2%) and 11 female (2.5%). The results showed that all
values of PFTs in smokers were reduced. There were significant negative correlations between smoking duration and rate as
pack/year and values of PFT (p < 0.05).
Conclusions: In this study the prevalence of smoking in the population of Mashhad city was shown for the first time. The
effect of smoking on PFTs showed that smoking leads to constriction of large and medium airways, which is due to duration
and rate of smoking.
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Streszczenie
Wstęp: Palenie tytoniu jest główną przyczyną przewlekłej obturacyjnej choroby płuc. Celem niniejszego badania było
określenie rozpowszechnienia palenia tytoniu w populacji miasta Mashhad  oraz przeprowadzenie testów czynnościowych
płuc u osób palących.
Materiał i metody: Rozpowszechnienie palenia tytoniu określono za pomocą standardowego kwestionariusza. U wszystkich
osób palących wykonano badania czynnościowe płuc obejmujące pomiar natężonej pojemności życiowej (FVC), natężonej
objętości wydechowej  pierwszosekundowej (FEV1), przepływu środkowowydechowego (MMEF), szczytowego przepływu
wydechowego (PEF) i maksymalnego  przepływu wydechowego przy FVC równej 75, 50 i 25% (MEF75, 50, 25).
Wyniki: W badaniu wzięło udział 1435 osób, 999 mężczyzn i 436 kobiet. Palenie tytoniu zadeklarowały 183 (12,7%) osoby
spośród respondentów — 172 mężczyzn (17,2%) i 11 kobiet (2,5%). Wszystkie wyniki badań czynnościowych płuc u osób
palący były obniżone. Zaobserwowano istotą ujemną korelację między czasem palenia tytoniu i liczbą paczek papierosów
wypalanych w ciągu roku a parametrami ocenianymi w badaniach czynnościowych (p < 0,05).
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Introduction
Chronic obstructive pulmonary disease
(COPD) is a major cause of chronic morbidity thro-
ughout the world. Many people suffer from this
disease for years and die prematurely from it or its
complications. COPD is currently the fourth le-
ading cause of death in the world [1], and a fur-
ther increase in its prevalence and COPD-related
mortality is predicted for the coming decades [2].
Cigarette smoking is by far the most important
risk factor for COPD and the most important way
that tobacco contributes to the risk of COPD [3].
Smoking leads to a rapid decline in pulmonary func-
tion tests (PFTs), especially those indicating the
diameter of airways, such as forced expiratory flow
in one second (FEV1) [4]. The differences between
cigarette smokers and non-smokers increase in di-
rect proportion to the quantity of smoking. Even in
teenagers who have smoked for only a few years,
maximum expiratory flow-volume curves demon-
strate decreases in flow rates at small lung volumes
[5]. The effect of acute smoking on airway calibre
was also documented by Ress et al. [6]. The obstruc-
tion to airflow that develops in 15 to 20% of heavy
smokers is thought to be due to abnormalities in
airways with less than 2 mm internal diameter [7].
It is believed that the airway obstruction in COPD
and the decline in PFTs are irreversible.
Therefore, in the present study the prevalen-
ce of smoking in the city of Mashhad and the ef-
fect of the quantity and duration of smoking on
PFTs were examined.
Material and methods
Study area and population
One thousand four hundred and thirty-five sub-
jects (999 M and 436 F) were interviewed from
21 randomly selected areas in the city of Mashhad. Data
regarding the prevalence of smoking were collected.
The city of Mashhad has moderate industry and he-
avy traffic. Mashhad is a holy city located in the north
east of Iran with a population of two-million people,
many of whom are immigrants from all over Iran. The
study was performed in March — July 2008.
Wnioski: W niniejszym badaniu po raz pierwszy oceniono  odsetek osób palących w populacji Mashhadu. Ocena parame-
trów czynnościowych płuc wykazała, że palenie tytoniu prowadzi do zwężenia dużych i średnich oskrzeli, a efekt ten zależy
od długości okresu palenia i od liczby wypalanych papierosów.
Słowa kluczowe: rozpowszechnienie palenia tytoniu, czas palenia tytoniu, liczba wypalanych papierosów, testy
czynnościowe płuc
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Protocol
A Persian language questionnaire was used to
assess the prevalence of smoking among the popu-
lation of the city of Mashhad.
Pulmonary function tests of smokers and a con-
trol group were measured using a spirometer with
a pneumotachograph sensor (Model ST90, Fukuda,
Sangyo Co., Ltd. Japan). The control group (150 sub-
jects) were chosen from the same areas of the city with
similar age, height, and sex with no previous history
of respiratory disease. Prior to pulmonary function
testing, the required manoeuvre was demonstrated by
a trained final medical student, and subjects were
encouraged and supervised throughout test perfor-
mance. Pulmonary function testing was performed
using the acceptability standards outlined by the
American Thoracic Society (ATS), with subjects in
a standing position and wearing nose clips [8]. All tests
were carried out between 10.00 and 17.00 hours. Pul-
monary function tests were performed three times in
each subject with an acceptable technique. The hi-
ghest level for forced vital capacity (FVC), forced expi-
ratory volume in one second (FEV1), peak expiratory
flow (PEF), maximal mid expiratory flow (MMEF), and
maximal expiratory flow at 75%, 50%, and 25% of the
FVC (MEF75, MEF50, and MEF25, respectively) were ta-
ken independently from the three curves. The PFT
values were presented as percent predicted [9, 10]. The
study was approved by the ethical committee of Ma-
shhad University of Medical Sciences.
Data analysis
The data of PFT values and age were expressed
as mean ± SD and data of smoking as percentage of
total studied population of each group. The correla-
tion between PFT values and duration and quantity
of smoking was performed using regression analy-
sis. A two-sided p value of 0.05 was the criterion for
statistical significance. All analyses were performed
with SPSS software (version 11.5, SPSS Inc. USA).
Results
Prevalence of smoking
The prevalence of smoking among interviewed
subjects was 12.7% (183 among 1435 interviewed
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Table 1. Smoking prevalence, smoking amount, and duration in different age groups
Tablela 1. Rozpowszechnienie palenia tytoniu, liczba wypalonych papierosów i okresów palenia w różnych grupach wiekowych
Age (years)/ Male/ Female/ Total/ S — amount S — duration
/Wiek (lata) /Mężczyźni /Kobiety /Razem
Stu S % Stu S % Stu S % Pack/Y Y
10–19 14 2 14.3 15 0 0 29 2 6.9 2.0 ± 1.41 3.5 ± 0.71
20–29 175 30 17.1 53 1 1.9 228 31 13.6 5.0 ± 5.94 7.9 ± 2.79
30–39 285 52 18.2 114 2 1.7 399 54 13.5 9.4 ± 9.33 11.8 ± 5.43
40–49 267 49 18.4 132 2 1.5 399 51 13.5 15.3 ± 15.86 18.4 ± 10.01
50–59 162 26 16.0 73 3 4.1 235 29 12.3 20.8 ± 27.31 20.7 ± 12.65
60–69 68 10 17.7 42 2 4.7 110 12 10.9 21.8 ± 9.73 31.7 ± 9.35
> 70 28  3 10.7 7 1 8.0 35 4 11.4 58.3 ± 36.86 36.6 ± 11.54
Total/Razem 999 172 17.2 436 11 2.5 1435 183 12.7 13.8 ± 16.66 16.0 ± 10.62
Stu — studied subjects; S — smokers; % — prevalence of smoking (percentage); Y — year
Table 2. Smoking prevalence in different income (Rial) level groups
Tabela 2. Rozpowszechnienie palenia tytoniu w zależności od dochodów (w rialach)
Income (year) Studied subjects/ Smokers/ Prevalence (%)
Roczny dochód /Grupa badana /Palacze /Odsetek palących (%)
> 10,000,000 45 3 6.6
5,000,000–10,000,000 290 30 10.3
3,000,000–5,000,000 430 41 9.5
1,500,000–3,000,000 610 102 16.7
< 1,500,000 60 7 11.6
One thousand Rial is equal to one US dollar
Table 3. Smoking prevalence in different educational level groups
Tabela 3. Rozpowszechnienie palenia tytoniu w zależności od wykształcenia
Educational level/Skala edukacji Studied subjects/Grupa badana Smokers/Palacze Prevalence (%)/Odsetek palących (%)
Highly educated 52 3 5.8
Medium educated 741 83 11.2
Poorly educated 642 97 15.1
The highly educated group consisted of subjects with B.Sc. level and above; the medium educated group are subjects who attended high school; and the poorly educated
group are subjects who did not attend high school
subjects). The rate of smoking among male subjects
was 17.2% (172 of 999 subjects) and in female sub-
jects 2.5% (11 of 436) (Table 1). The prevalence of
smoking was higher among people with lower in-
come, except those with very low income (Table
2). The rate of smoking was higher in the poorly
educated population (Table 3).
The smoking prevalence was higher in male sub-
jects aged 20–69 and in female subjects aged 50–70
than in the remaining age groups (Table 1).
Pulmonary function tests
All PFT values of smokers were significan-
tly lower than those of the control group of the
same age, height and sex distribution (p < 0.001
for all cases) (Table 4). There were weak but si-
gnificant negative correlations between both
duration and amount of smoking with all PFT
values (r = –0.155–0.305, p < 0.05 for all cases).
Twenty-three percent of smokers (41 subjects) and
only 4% of controls (6 subjects) showed FVC of less
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than 80% of the predicted values. In addition, 19%
of smokers (34 subjects) and only 5% of controls
(8 subjects) showed FEV1 of less than 80% of the
predicted values. The number of patients with
FEV1/VC% less than 70% was 24 (13%).
Discussion
In the present study, which was performed in
the population sample, the prevalence of smoking
in the city of Mashhad (north east Iran) was studied.
PFT values of smokers were also evaluated. The
results showed that 12.7% of the population of the
city are regular smokers. The prevalence of smoking
was much lower in females (2.5%) compared to
males (17.2%). The smoking rate was highest in men
aged 20–69 years (17.1–18.4%) and women aged
50–70 (4.1–8%). The smoking prevalence was higher
in the poorly educated population and in people with
lower income (except the very low income group).
The results of the study of Ahmadi et al. sho-
wed a higher prevalence of smoking in the city of
Shiraz (18.7%) [11]. The sample population of their
study was smaller than the present study, which
might be the reason of the differences in the pre-
valence of smoking between the two studies. The
other reason for the differences in the prevalence
of smoking between Shiraz and Mashhad city co-
uld be differences in the culture of the populations
of the two cities. However, the results of the study
of Ahmadi et al. also showed a higher prevalence
of smoking among males (26%) compared to fema-
les (3.6%), similar to the results of the present stu-
dy. Their results also showed that the average age
of starting smoking in Shiraz is 21 years, which is
very similar to the results for Mashhad city shown
in the present study. In another study, Ahmadi et
al. showed a smoking prevalence of 25% among
nursing students in Iran [12]. Turcić et al. showed
a higher smoking prevalence among male (27.2%)
compared to female subjects (12.6%) the among
population of Zagreb [13]. However, the differen-
ce in smoking prevalence between males and fema-
les in this part of Europe is much lower than that of
the Iranian population. The higher duration of smo-
king seen for older age groups in our study as well
as Turcić et al. [13] is expected. However, the hi-
gher amount of smoking in the older population
seems to be an important health issue.
The results also showed a reduction of most
values of pulmonary function tests in smokers.
Although the FEV1/FVC ratio in the majority of
smokers was within the normal range, these valu-
es were also significantly lower than in non-smo-
kers, confirming the effect of smoking on the re-
spiratory system. There were also negative corre-
lations between all PFT values and both quantity
and duration of smoking. Several previous studies
[14–20] also showed reductions of different valu-
es of PFTs among smokers compared to normal
subjects. The results of the present study show the
reduction in PEF and MEF75 among smokers com-
pared to non-smokers was more prominent than
the reduction of other PFT values.
The results of our study were supported by
previous studies indicating a reduction of prima-
rily PEF, MMEF, and MEF75 in smokers [21–24].
The results of our previous study in a smaller po-
pulation and in mild smokers showed similar re-
sults, i.e. greater reduction in PEF and MEF75 than
other PFT values among smoker subjects [25]. As
indicated in the method section, every effort was
Table 4. Pulmonary function tests (PFT) of studied smokers and non-smokers and statistical differences between the two
groups
Tabela 4. Badania czynnościowe płuc w grupie osób palących i niepalących
PFT values/Wyniki PFT Smokers/Palacze Non-smokers/Niepalący Statistical difference/Różnice statystyczne
FVC 76.40 ± 10.40 87.86 ± 14.70 p < 0.001
FEV1 78.30 ± 13.50 91.00 ± 14.00 p < 0.001
FEV1/FVC 96.45 ± 13.81 104.17 ± 8.67 p < 0.001
MMEF 81.69 ± 25.00 91.04 ± 13.00 p < 0.001
PEF 59.41 ± 20.00 92.00 ± 18.80 p < 0.001
MEF75 61.80 ± 34.00 97.05 ± 17.91 p < 0.001
MEF50 80.18 ± 26.20 93.18 ± 15.00 p < 0.001
MEF25 90.51 ± 24.80 98.60 ± 24.31 p < 0.001
Values presented as mean ± SD of percent predicted (for smokers and non-smokers n = 183 and 150, respectively); FVC — forced vital capacity, FEV1 — forced expiratory
volume in one second; MMEF — maximal mid-expiratory flow; PEF — peak expiratory flow; MEF75, MEF50, MEF25 — maximal expiratory flow at 75%, 50%, and 25% of the FVC,
respectively;
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made to perform PFT measurements correctly; the-
refore, the great reduction in PEF and MEF75 seen
in this study is unlikely to be due to poor coopera-
tion regarding PFT measurements in some subjects.
The results of the present study also showed
weak but significant negative correlations betwe-
en decreases in all values of PFTs and parameters
such as amount and duration of smoking. The stu-
dies of Sherrill et al. [26] and Verschakelen et al.
[27] also showed correlations between the amount
of smoking and a reduction in most values of PFTs,
supporting the results of the present study.
The limitations of the present study are: the
possible poor cooperation of subjects in performing
PFT measurements for small proportion of sub-
jects, and the subjective character of questions re-
garding smoking. In addition, the prevalence of
smoking should also be examined in rural areas
of northeast Iran as well as urban and rural areas
of other parts of the country.
Conclusions
In conclusion, the results of the present stu-
dy showed a 12.7% prevalence of smoking among
the population of the city of Mashhad, which was
much higher in males (17.2%) than in females
(2.5%). The smoking prevalence was greater in
people with lower income and lower level of educa-
tion. The rate of smoking was also higher among the
middle-aged population. The results also demonstra-
ted the significant effect of smoking on PFTs.
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